Search Results 1751-1760 of 17027 for monoclonal antibody

1. A Study of Subcutaneous Nivolumab + Relatlimab FDC in Previously Untreated Metastatic or Unresectable Melanoma - Mayo Clinic

   ... antibody (except if given as adjuvant or neoadjuvant therapy for melanoma), or any other antibody or drug specifically targeting T-cell co-stimulation or ...

2. Neuromyelitis Optica Clinical Consortium (NMOCC) Clinical Database Development for Neuromyelitis Optica Spectrum Disorders - Mayo Clinic

   NMO seropositive patients are those who have a circulating antibody, NMO-IgG, against aquaporin-4. NMO seronegative patients are those who likely have NMO ...

3. A Study to Better Understand if Diet and Metabolism are Connected with MS Relapses and Disease Progress in Patients with Pediatric-onset MS - Mayo Clinic

   Are positive for AQP4 antibodies or high suspicion of neuromyelitis optica spectrum disorder; OR; Are pregnant or breast-feeding. Participating Mayo Clinic ...

4. Endpoint Determination Study Protocol - Mayo Clinic

   A positive IgG antibody response for at least one food in the Biomerica InFoods® IBS panel. Patients who are on stable (> 3 months) doses of medications or ...

5. Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial - Mayo Clinic

   ... antibody panels are used and functional assays are performed. Chosen ECOG treatment clinical trial must be active and accruing. Patient must not have begun ...

6. Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma - Mayo Clinic

   ... monoclonal protein > 800 mg/dL; ANC ≥ 1200/uL; Hgb > 9 g/dl; PLT ≥ 50,000/uL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or if total bilirubin is ...

7. mRNA transfection improves CTL response in immunotherapy - Mayo Clinic

   In a 2022 study, Mayo Clinic researchers found that by transfecting cytotoxic CD8+ T cells with mRNA of natural killer cells they can improve response in ...

8. Universal blood donor type: Is there such a thing? - Mayo Clinic

   Type O negative is the blood type most often given to people who need donated blood in an emergency.

9. A Study of TNB-383B in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   The purpose of this study is to evaluate the safety, clinical pharmacology and clinical activity of TNB-383B, a T-cell engaging bispecific antibody, in ...

10. Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung - Mayo Clinic

    hypersensitivity reactions to chimeric or humanized antibodies, including ... disease, antiphospholipid antibody syndrome, Wegener grandulomatosis, Sjogren